Close Menu

antibodies

The FDA has confirmed to DxS that its TheraScreen KRAS test is a Class III device. The company is in the process of submitting its premarket approval application to the agency.

In Print: Mar 3, 2009

Premium

Microarray-Related Papers of Note, February 2009

News Scan: Feb 27, 2009

Premium

DiscoveryBioMed, ArtusLabs, Heptares Therapeutics, Gentronix, GlaxoSmithKline, BioFocus DPI, Eli Lilly, Millipore, Epitome, ChanTest, Applied Cell Sciences, BioTime, Embryome Sciences, Reproductive Genetics Institute of Chicago, Arizona State University Biodesign Institute, VisionGate

BioGenes will supply antibodies for the project, called cNeupro. The deal will enable it to share ownership of the antibodies and pocket royalties on the ones that lead to commercial products.

Industry Briefs: Feb 26, 2009

Premium

Mosaiques, Bruker, Kinaxo, Xencor, CSL, Hybrigenics, Adlyfe, Wyeth

New Products: Feb 26, 2009

Premium

Agilent, GWC Technologies, Pall Life Sciences, AnaSpec

Millipore said that the technology will be used to develop a range of new multiplex immunoassay kits that can be used with the Luminex xMAP platform.

The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.

Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.

Not That Kind of ESP

Premium

Harvard researchers have built a computational tool that they believe could help get more protein biomarkers into clinical use.

Pages

A Harvard University professor has been charged with making false claims regarding funds he received from China, the New York Times reports.

Discover magazine reports that animal dissections might dissuade students from science careers, but that a firm has developed synthetic frogs for dissections.

Nature News reports that a US panel is reviewing current guidelines for federally funded gain-of-function viral research.

In PNAS this week: de novo mutation patterns among the Amish, an alternative RNA-seq method, and more.